Search results
Start date:
May 18, 2025
End date:
May 18, 2025
Radcliffe Medical Education is hosting a symposium entitled 'Addressing the Challenges in Cardiorenal Patient Care' at theHeart Failure Association (HFA)in Belgrade (RS) on Sunday 18 May 2025 at 12:30–13:30 CEST.OverviewIn this symposium, join Dr Kieran Docherty (Glasgow, UK), Prof Clara Saldarriaga (Medellin, CO) and Prof Gianluigi Savarese (Stockholm, SE) as they explore the complexities of…
View more
Author(s):
Michelle Kittleson
Added:
1 year ago
AHA Conference 2024 - In this highlights video from AHA 2024, Dr Michelle Kittleson (Cedars-Sinai California Heart Center, US) offers a concise and insightful summary of the most influential late-breaking trials presented at the conference. Dr Kittleson discusses the pivotal studies poised to impact clinical practice and enhance patient outcomes in heart failure care.Trials covered in detail…
View more
Roger S Blumenthal
Job title: The Kenneth Jay Pollin Professor of Cardiology, Professor of Medicine
Author
An Expert Approach to Cardio-Renal Protection in CKD
Video Series
Author(s):
Sheldon E Litwin
,
Christian C Faaborg-Andersen
,
Ryan J Tedford
Added:
1 year ago
Added:
1 year ago
Source:
Radcliffe CVRM
A recent study published in Circulation: Heart Failure1 has found that multimorbidity, the presence of two or more chronic health conditions, substantially increases the risk of mortality in patients with heart failure who have mildly reduced (HFmrEF) or preserved ejection fraction (HFpEF).The study analyzed data from two major heart failure trials: TOPCAT-Americas (Treatment of Preserved Cardiac…
View more
Author(s):
Harriette Van Spall
,
Mikhail Kosiborod
Added:
1 year ago
AHA Conference 2024 — REALIZE-K: Impact of sodium zirconium cyclosilicate (SZC) on HFrEF patient's potassium levels whilst on spironolactone.Late-Breaker Host, Dr Harriette Van Spall (McMaster University, CA) is joined onsite by Dr Mikhail Kosiborod (Saint Luke's Mid America Heart Institute, US) to discuss the findings from the REALIZE-K Study (NCT04676646; AstraZeneca).REALIZE-K is a phase 4…
View more
Heart Failure in Sub-Saharan Africa: Systems of Care
Author(s):
Victor M Wauye
,
Dzifa Ahadzi
,
Krishna Udayakumar
,
et al
Added:
11 months ago
Review Article
Frailty in Cardio-oncology
Author(s):
Ilaria Torre
,
Lorenzo Tinti
,
Ludovica Amore
,
et al
Added:
2 months ago
Review Article
Author(s):
Felipe Martínez
Added:
2 weeks ago
ACC.26 - In this expert interview filmed at ACC.26 in New Orleans, Prof. Felipe Martínez discusses how late-breaking heart failure data are reshaping contemporary pharmacological management. The conversation focuses on new spironolactone results, advanced hemodynamic strategies in HFpEF, and the expanding role of cardiometabolic therapies, including GLP‑1 receptor agonists, in optimising outcomes…
View more